Paul S. Jellinger, MD, MACE is Past President of the American College of Endocrinology (ACE) and is a Past President of the American Association of Clinical Endocrinologists (AACE). He is a Professor of Medicine on the voluntary faculty at the University of Miami. In May 2004, he became a Master of the American College of Endocrinology.
After receiving his medical degree from Wayne State University School of Medicine, Dr. Jellinger completed a first-year medical residency at Beth Israel Hospital and a second-year residency at Mount Sinai Hospital in New York City. He subsequently was awarded an NIH fellowship in Endocrinology at Mount Sinai Hospital. Dr. Jellinger has served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. He is involved in many regional and national professional and scientific associations including The Endocrine Society and the American Diabetes Association and is Past President of The Florida Endocrine Society. Dr. Jellinger is board certified in internal medicine and endocrinology and metabolism. He has also conducted investigative research on over 50 subjects and is currently conducting research for several major pharmaceutical companies. He now serves as medical editor of Clinical
Dr. Jellinger, a founding member, was elected President of the American Association of Clinical Endocrinologists, a 5500 physician member organization, in May 2000. He has been active on the AACE Board of Directors and has served as chairman of several committees including the Clinical Research Committee. Dr. Jellinger was also a member of the taskforces that defined and published the AACE Guidelines for the “Management of Diabetes Mellitus” the “Evaluation and Treatment of Hyperthyroidism and Hypothyroidism” and the “Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.” He served as Chairman of the Task Force for the published AACE Guidelines on the “Treatment of Lipid Disorders in the Prevention of Atherogenesis”. He was a participant in the 2001 and 2002 ACE/AACE Consensus Conferences on Glycemic Control and The Insulin Resistance Syndrome and was co-chairman of the recent ACE/AACE Diabetes Consensus Conference on Implementation of Glycemic Goals. He now serves as co-chair of the AACE Diabetes Treatment Roadmap Task Force. Dr. Jellinger lectures frequently on topics related to diabetes mellitus and lipid disorders.